Literature DB >> 548604

Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

S G Rostand, J C Gretes, K A Kirk, E A Rutsky, T E Andreoli.   

Abstract

The 6-year cumulative incidence of ischemic heart disease (IHD) in 382 dialysis patients (mean age [SEM], 43 +/- 0.7 years) was studied. Of 101 patients with IHD, only 39 developed symptoms following dialysis (cumulative incidence, 20.8%). This group was older than those with IHD, and in 55%, IHD occurred in the first year of dialysis. Analysis by sex and race showed the rate of IHD in men and women to be similar, but the rate in whites was twice that in blacks. In men, the rate was not different from nondialysis men with similar coronary risk factors, whereas in dialysis women, the rate was twice that of nondialysis cohort. The development of IHD did not adversely affect long-term survival in patients without prior evidence of IHD. Death from myocardial infarction occurred in 3 of 320 patients ar risk. Atuopsy data in 33 patients revealed 70% stenosis of coronary arteries in 7, 4 of whom had antecedent disease. Our major conclusions are (a) the incidence of IHD during dialysis was not different from similarly matched nondialysis subjects; (b) the rate of IHD in dialysis women was greater than it was in nondialysis subjects; (c) coronary artery disease only affected long-term survival of patients with preexisting disease; (d) autopsy data did not suggest accelerated atherosclerosis.

Entities:  

Mesh:

Year:  1979        PMID: 548604     DOI: 10.1038/ki.1979.170

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Optimal hematocrit based on regional cerebral blood flow in hemodialysis patients with diabetic nephropathy.

Authors:  Tsuneyoshi Oh; Osamu Sakayori; Chisako Kamano; Yuichi Komaba; Yasuhiko Iino; Yasuo Katayama
Journal:  Clin Exp Nephrol       Date:  2002-09       Impact factor: 2.801

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

4.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

Authors:  H Dieplinger; P Y Schoenfeld; C J Fielding
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

5.  Relationship between major adverse cardiac events and angiographic findings in dialysis patients.

Authors:  F Fabbian; G Cacici; V De Biase; T Yabarek; C Gangemi; L Franceschini; A De Giorgi; P Benussi; A Lupo; F Portaluppi
Journal:  Int Urol Nephrol       Date:  2010-09-02       Impact factor: 2.370

6.  Renal function is associated with risk of atrial fibrillation after cardiac surgery.

Authors:  Johann Auer; Gudrun Lamm; Thomas Weber; Robert Berent; Choi-Keung Ng; Michael Porodko; Bernd Eber
Journal:  Can J Cardiol       Date:  2007-09       Impact factor: 5.223

7.  Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.

Authors:  P Grützmacher; E H Scheuermann; W Siede; P D Lang; U Abshagen; H W Radtke; C A Baldamus; W Schoeppe
Journal:  Klin Wochenschr       Date:  1986-10-01

Review 8.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

9.  Cardiovascular pathology in renal transplant recipients.

Authors:  E B Frye; N D Vaziri; D C Martin; S Farooqui
Journal:  J Natl Med Assoc       Date:  1986-12       Impact factor: 1.798

10.  Continuous ambulatory peritoneal dialysis: no longer experimental.

Authors:  G Wu; R Khanna; S I Vas; G Digenis; D G Oreopoulos
Journal:  Can Med Assoc J       Date:  1984-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.